Edgewise Therapeutics (EWTX) shares were down more than 3% early Thursday after the company reported a Q1 net loss of $0.43 per diluted share, widening from $0.42 the preceding quarter.
Analysts polled by FactSet expected a GAAP loss of $0.43 per share.
No revenue was reported for the quarter ended March 31.
Price: 14.06, Change: -0.46, Percent Change: -3.17
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。